VIEMED HEALTHCARE, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Viemed Healthcare, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q2 2024.
  • Viemed Healthcare, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.62M, a 10.1% increase year-over-year.
  • Viemed Healthcare, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $6.04M, a 10% increase year-over-year.
  • Viemed Healthcare, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.85M, a 12.4% increase from 2022.
  • Viemed Healthcare, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.2M, a 1.01% increase from 2021.
  • Viemed Healthcare, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.15M, a 5.49% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.04M $1.62M +$149K +10.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $5.89M $1.43M +$41K +2.95% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $5.85M $1.53M +$217K +16.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $5.63M $1.45M +$144K +11% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $5.49M $1.47M +$200K +15.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $5.29M $1.39M +$86K +6.59% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $5.2M $1.32M +$12K +0.92% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $5.19M $1.31M +$7K +0.54% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $5.18M $1.27M +$35K +2.83% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $5.15M $1.31M -$2K -0.15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $5.15M $1.31M +$4K +0.31% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $5.15M $1.3M +$68K +5.51% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $5.08M $1.24M +$40K +3.34% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $5.04M $1.31M +$156K +13.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $4.88M $1.3M +$393K +43.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $4.49M $1.23M +$170K +16% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $4.32M $1.2M +$162K +15.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $4.16M $1.15M +$271K +30.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 $3.89M $908K +$104K +12.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 $3.78M $1.06M +$392K +58.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $3.39M $1.03M +$369K +55.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $3.02M $880K +$319K +56.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $2.7M $804K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 $672K Jul 1, 2018 Sep 30, 2018 10-K 2020-03-04
Q2 2018 $665K Apr 1, 2018 Jun 30, 2018 10-K 2020-03-04
Q1 2018 $561K Jan 1, 2018 Mar 31, 2018 10-K 2020-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.